甲状腺癌幸存者代谢综合征风险是否增加?
基于韩国国民健康与营养调查(KNHANES)2007-2014年数据,分析34,347名受试者,比较无甲状腺癌史者、诊断后3年内短期幸存者(95例)和诊断后3年以上长期幸存者(60例)的代谢综合征风险。短期幸存者代谢综合征、高血压和高空腹血糖风险显著升高,长期幸存者无显著关联。
要点
- 短期幸存者代谢综合征风险升高(OR 1.986,95%CI 1.0-3.70,p=0.030)。
- 短期幸存者高血压风险升高(OR 2.115,95%CI 1.23-3.64,p=0.006)。
- 短期幸存者高空腹血糖风险升高(OR 1.792,95%CI 1.03-3.11,p=0.038)。
核心结论
- 与无甲状腺癌史者相比,短期幸存者代谢综合征、高血压和高空腹血糖风险升高,而长期幸存者无显著关联。
研究设计与样本
- 基于韩国国民健康与营养调查(KNHANES)IV-VI(2007-2014年)的群体数据,排除年龄小于19岁、空腹间隔小于8小时及预定义变量(包括代谢综合征组分)数据不完整者后,分析34,347名受试者。
- 比较三组:无甲状腺癌史者、调查日期前3年内诊断甲状腺癌者(短期幸存者,95例)、调查日期前3年以上诊断者(长期幸存者,60例)。
主要发现
- 短期幸存者代谢综合征风险较无甲状腺癌史者升高(OR 1.986,95%CI 1.0-3.70,p=0.030)。
- 短期幸存者高血压风险较无甲状腺癌史者升高(OR 2.115,95%CI 1.23-3.64,p=0.006)。
- 短期幸存者高空腹血糖风险较无甲状腺癌史者升高(OR 1.792,95%CI 1.03-3.11,p=0.038)。
- 长期幸存者与无甲状腺癌史者相比,未观察到显著关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The steep rise in thyroid cancer observed in recent decades has caused an increase in the population of long-term thyroid cancer survivors. Other than recurrences of cancer, the long-term health consequences of surviving thyroid cancer, particularly metabolic syndrome, have not yet been determined. The aim of this study was to estimate the risk of metabolic syndrome in thyroid cancer survivors. MATERIALS AND METHODS: Population-based data from the Korean National Health and Nutrition Examination Survey (KNHANES) were used for the analysis. The data of KNHANES IV-VI from 2007-2014 were obtained. After excluding subjects who were under 19 years old, whose fasting interval was less than 8 hours, and whose data for predefined variables including metabolic syndrome components were incomplete, 34,347 subjects were analyzed. The incidence of metabolic syndrome and its components were evaluated in three groups: subjects with no history of thyroid cancer, subjects diagnosed with thyroid cancer within 3 years of the survey date, and subjects diagnosed more than 3 years before the survey date. RESULTS: Thyroid cancer diagnoses were made within 3 years of the survey date for 95 subjects (group 1, short-term survivors) and more than 3 years earlier than the survey date for 60 subjects (group 2, long-term survivors). Metabolic syndrome was frequently observed with clinical significance (odds ratio [OR] 1.986 [95% confidence interval [CI] 1.0-3.70], p = 0.030) in short-term survivors compared with subjects with no thyroid cancer history. Risks for having high blood pressure and high fasting glucose were estimated to be higher in the short-term survivor group (OR 2.115 [CI 1.23-3.64], p = 0.006 and OR 1.792 [CI 1.03-3.11], p = 0.038, respectively). No significant associations were noticed in the long-term survivor group when compared with the group with no thyroid cancer history. CONCLUSION: Risks for metabolic syndrome, especially high blood pressure and high fasting glucose, were increased in short-term survivors of thyroid cancer but not in long-term survivors when compared with subjects with no history of thyroid cancer.
引用
- Kim MH, Huh JY, Lim DJ, et al. Does the Risk of Metabolic Syndrome Increase in Thyroid Cancer Survivors? Thyroid. 2017. PMID: 28393666. doi:10.1089/thy.2016.0624
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。